The Centers for Disease Control and Prevention (CDC) last week released new interim clinical guidelines for evaluating and treating cases of e-cigarette, or vaping, product use associated lung injury (EVALI). This guidance updates an earlier release from the CDC and is based on more recent cases. Twenty-six people from 21 states had died from EVALI as of Oct. 11, according to the CDC. As of Tuesday, three Hoosiers had died.

The new interim guidance covers:

• Initial clinical evaluation.
• Suggested criteria for hospital admission and treatment.
• Patient follow-up.
• Special considerations for groups at high risk.
• Clinical and public health recommendations.

Read the new clinical guidance from the CDC here.